Abstract
Purpose
Choriocapillaris insufficiency may play a role in centripetal retinitis pigmentosa (RP) progression involving the fovea. However, the relationship between choriocapillaris integrity and foveal damage in RP is unclear. We examined the relationship between choriocapillaris flow and the presence of foveal photoreceptor involvement in RP.
Methods
We categorized the severity of central involvement in RP by the occurrence of foveal ellipsoid zone (EZ) disruption: present (severe RP) or absent (mild RP). Using optical coherence tomography angiography (OCTA, AngioVue, Optovue) in cases and unaffected age-matched controls, we compared vessel density (VD) between the groups using the generalized linear mixed model, controlling for age, gender, and scan quality.
Results
Fifty-seven eyes (20 severe RP, 18 mild RP, and 19 controls) were included. Foveal and parafoveal mean outer retinal thickness (µm) were lower in severe RP (fovea: 101.3 ± 14.5; parafovea: 68.4 ± 11.7) than controls (fovea: 161.2 ± 8.9; parafovea: 142.1 ± 11.8; p ≤ 0.001) and mild RP (fovea: 162.0 ± 14.7; parafovea: 116.8 ± 29.4; p ≤ 0.0001). Foveal choriocapillaris VD (%) was lower in severe RP (56.7 ± 6.8) than controls (69.9 ± 4.6; p = 0.008) and mild RP (65.3 ± 5.3; p = 0.01). The parafoveal choriocapillaris VD was lower in severe RP than controls (64.4 ± 5.9 vs. 68.3 ± 4.1; p = 0.04) but no different than in mild RP (p = 0.4).
Conclusion
Choriocapillaris flow loss was associated with fovea-involving photoreceptor damage in RP. Further research is warranted to validate this putative association and clarify causation. Choriocapillaris imaging using OCTA may provide information to supplement structural OCT findings when evaluating subjects with RP in neuroprotective or regenerative clinical trials.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00417-021-05223-y/MediaObjects/417_2021_5223_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00417-021-05223-y/MediaObjects/417_2021_5223_Fig2_HTML.png)
Similar content being viewed by others
References
Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet 368(9549):1795–1809. https://doi.org/10.1016/S0140-6736(06)69740-7
Zhang Q (2016) Retinitis pigmentosa: progress and perspective. Asia Pac J Ophthalmol (Phila) 5(4):265–271. https://doi.org/10.1097/APO.0000000000000227
Henkind P, Gartner S (1983) The relationship between retinal pigment epithelium and the choriocapillaries. Trans Ophthalmol Soc UK 103(Pt 4):444–447
Blaauwgeers HG, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, Alitalo K, Kroon ME, Kijlstra A, van Hinsbergh VW, Schlingemann RO (1999) Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol 155(2):421–428. https://doi.org/10.1016/S0002-9440(10)65138-3
Guduru A, Al-Sheikh M, Gupta A, Ali H, Jalali S, Chhablani J (2018) Quantitative assessment of the choriocapillaris in patients with retinitis pigmentosa and in healthy individuals using OCT angiography. Ophthalmic Surg Lasers Imaging Retina 49(10):e122–e128. https://doi.org/10.3928/23258160-20181002-14
Korte GE, Reppucci V, Henkind P (1984) RPE destruction causes choriocapillary atrophy. Invest Ophthalmol Vis Sci 25(10):1135–1145
Dhoot DS, Huo S, Yuan A, Xu D, Srivistava S, Ehlers JP, Traboulsi E, Kaiser PK (2013) Evaluation of choroidal thickness in retinitis pigmentosa using enhanced depth imaging optical coherence tomography. Br J Ophthalmol 97(1):66–69
Cellini M, Strobbe E, Gizzi C, Campos EC (2010) ET-1 plasma levels and ocular blood flow in retinitis pigmentosa. Can J Physiol Pharmacol 88(6):630–635. https://doi.org/10.1139/Y10-036
Miyata M, Oishi A, Hasegawa T, Oishi M, Numa S, Otsuka Y, Uji A, Kadomoto S, Hata M, Ikeda HO, Tsujikawa A (2019) Concentric choriocapillaris flow deficits in retinitis pigmentosa detected using wide-angle swept-source optical coherence tomography angiography. Invest Ophthal Vis Sci 60(4):1044–1049
Rezaei KA, Zhang Q, Chen CL, Chao J, Wang RK (2017) Retinal and choroidal vascular features in patients with retinitis pigmentosa imaged by OCT based microangiography. Graefes Arch Clin Exp Ophthalmol 255(7):1287–1295. https://doi.org/10.1007/s00417-017-3633-x
Mastropasqua R, D’Aloisio R, De Nicola C, Ferro G, Senatore A, Libertini D, Di Marzio G, Di Nicola M, Di Martino G, Di Antonio L, Toto L (2020) Widefield swept source OCTA in retinitis pigmentosa. Diagnostics (Basel) 10(1):50. https://doi.org/10.3390/diagnostics10010050
Liu R, Lu J, Liu Q, Wang Y, Cao D, Wang J, Wang X, Pan J, Ma L, ** C, Sadda S, Luo Y, Lu L (2019) Effect of choroidal vessel density on the ellipsoid zone and visual function in retinitis pigmentosa using optical coherence tomography angiography. Invest Ophthal Vis Sci 1(60):4328–4335
Hanyuda N, Akiyama H, Shimoda Y, Mukai R, Sano M, Shinohara Y, Kishi S (2017) Different filling patterns of the choriocapillaris in fluorescein and indocyanine green angiography in primate eyes under elevated intraocular pressure. Invest Ophthalmol Vis Sci 58(13):5856–5861. https://doi.org/10.1167/iovs.17-22223
Jia Y, Bailey ST, Hwang TS, McClintic SM, Gao SS, Pennesi ME, Flaxel CJ, Lauer AK, Wilson DJ, Hornegger J, Fujimoto JG, Huang D (2015) Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. Proc Natl Acad Sci U S A 112(18):E2395-2402. https://doi.org/10.1073/pnas.1500185112
Gao SS, Jia Y, Zhang M, Su JP, Liu G, Hwang TS, Bailey ST, Huang D (2016) Optical coherence tomography angiography. Invest Ophthal Vis Sci 57(9):OCT27–OCT36
McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M (2015) ISCEV Standard for full-field clinical electroretinography. Doc Ophthalmol 130(1):1–12
Birch DG, Locke KG, Wen Y, Locke KI, Hoffman DR, Hood DC (2013) Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. JAMA Ophthalmol 131(9):1143–1150. https://doi.org/10.1001/jamaophthalmol.2013.4160
Team RC (2018) R: a language and environment for statistical computing. R Foundation for Statistical Computing,. https://www.R-project.org/. Accessed 24 Mar 2019
Pinheiro J, Bates D, DebRoy S, Sarkar D, Team RC (2018) nlme: linear and nonlinear mixed effects models. R package version 3.1–137. https://CRAN.R-project.org/package=nlme. Accessed 24 Mar 2019
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate-a practical and powerful approach to multiple testing. J R Stat Soc B 57(1):289–300
Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell’Osso L, Hertle R, Ma JX, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J (2008) Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med 358(21):2240–2248. https://doi.org/10.1056/NEJMoa0802315
Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N, Petersen-Jones S, Bhattacharya SS, Thrasher AJ, Fitzke FW, Carter BJ, Rubin GS, Moore AT, Ali RR (2008) Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med 358(21):2231–2239. https://doi.org/10.1056/NEJMoa0802268
Bennett J, Wellman J, Marshall KA, McCague S, Ashtari M, DiStefano-Pappas J, Elci OU, Chung DC, Sun J, Wright JF, Cross DR, Aravand P, Cyckowski LL, Bennicelli JL, Mingozzi F, Auricchio A, Pierce EA, Ruggiero J, Leroy BP, Simonelli F, High KA, Maguire AM (2016) Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet 388(10045):661–672. https://doi.org/10.1016/S0140-6736(16)30371-3
Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, McCague S, Cross D, Marshall KA, Walshire J, Kehoe TL, Reichert H, Davis M, Raffini L, George LA, Hudson FP, Dingfield L, Zhu X, Haller JA, Sohn EH, Mahajan VB, Pfeifer W, Weckmann M, Johnson C, Gewaily D, Drack A, Stone E, Wachtel K, Simonelli F, Leroy BP, Wright JF, High KA, Maguire AM (2017) Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390(10097):849–860. https://doi.org/10.1016/S0140-6736(17)31868-8
Takahashi VKL, Takiuti JT, Jauregui R, Tsang SH (2018) Gene therapy in inherited retinal degenerative diseases, a review. Ophthalmic Genet 39(5):560–568. https://doi.org/10.1080/13816810.2018.1495745
Maeda A, Mandai M, Takahashi M (2019) Gene and induced pluripotent stem cell therapy for retinal diseases. Annu Rev Genomics Hum Genet. https://doi.org/10.1146/annurev-genom-083118-015043
Iraha S, Tu HY, Yamasaki S, Kagawa T, Goto M, Takahashi R, Watanabe T, Sugita S, Yonemura S, Sunagawa GA, Matsuyama T, Fujii M, Kuwahara A, Kishino A, Koide N, Eiraku M, Tanihara H, Takahashi M, Mandai M (2018) Establishment of immunodeficient retinal degeneration model mice and functional maturation of human ESC-derived retinal sheets after transplantation. Stem Cell Reports 10(3):1059–1074. https://doi.org/10.1016/j.stemcr.2018.01.032
Shirai H, Mandai M, Matsushita K, Kuwahara A, Yonemura S, Nakano T, Assawachananont J, Kimura T, Saito K, Terasaki H, Eiraku M, Sasai Y, Takahashi M (2016) Transplantation of human embryonic stem cell-derived retinal tissue in two primate models of retinal degeneration. Proc Natl Acad Sci U S A 113(1):E81-90. https://doi.org/10.1073/pnas.1512590113
Pearson RA, Barber AC, Rizzi M, Hippert C, Xue T, West EL, Duran Y, Smith AJ, Chuang JZ, Azam SA, Luhmann UFO, Benucci A, Sung CH, Bainbridge JW, Carandini M, Yau KW, Sowden JC, Ali RR (2012) Restoration of vision after transplantation of photoreceptors. Nature 485(7396):99–103. https://doi.org/10.1038/nature10997
Singh MS, Charbel Issa P, Butler R, Martin C, Lipinski DM, Sekaran S, Barnard AR, MacLaren RE (2013) Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation. Proc Natl Acad Sci U S A 110(3):1101–1106. https://doi.org/10.1073/pnas.1119416110
Kruczek K, Gonzalez-Cordero A, Goh D, Naeem A, Jonikas M, Blackford SJI, Kloc M, Duran Y, Georgiadis A, Sampson RD, Maswood RN, Smith AJ, Decembrini S, Arsenijevic Y, Sowden JC, Pearson RA, West EL, Ali RR (2017) Differentiation and transplantation of embryonic stem cell-derived cone photoreceptors into a mouse model of end-stage retinal degeneration. Stem Cell Reports 8(6):1659–1674. https://doi.org/10.1016/j.stemcr.2017.04.030
Santos-Ferreira T, Postel K, Stutzki H, Kurth T, Zeck G, Ader M (2015) Daylight vision repair by cell transplantation. Stem Cells 33(1):79–90. https://doi.org/10.1002/stem.1824
Battaglia Parodi M, Cicinelli MV, Rabiolo A, Pierro L, Gagliardi M, Bolognesi G, Bandello F (2017) Vessel density analysis in patients with retinitis pigmentosa by means of optical coherence tomography angiography. Br J Ophthalmol 101(4):428–432. https://doi.org/10.1136/bjophthalmol-2016-308925
Sugahara M, Miyata M, Ishihara K, Gotoh N, Morooka S, Ogino K, Hasegawa T, Hirashima T, Yoshikawa M, Hata M, Muraoka Y, Ooto S, Yamashiro K, Yoshimura N (2017) Optical coherence tomography angiography to estimate retinal blood flow in eyes with retinitis pigmentosa. Sci Rep 7:46396. https://doi.org/10.1038/srep46396
Li XX, Wu W, Zhou H, Deng JJ, Zhao MY, Qian TW, Yan C, Xu X, Yu SQ (2018) A quantitative comparison of five optical coherence tomography angiography systems in clinical performance. Int J Ophthalmol 11(11):1784–1795. https://doi.org/10.18240/ijo.2018.11.09
Alnawaiseh M, Schubert F, Heiduschka P, Eter N (2019) Optical coherence tomography angiography in patients with retinitis pigmentosa. Retina 39(1):210–217. https://doi.org/10.1097/IAE.000000000000190
Inooka D, Ueno S, Kominami T, Sayo A, Okado S, Ito Y, Terasaki H (2018) Quantification of macular microvascular changes in patients with retinitis pigmentosa using optical coherence tomography angiography. Invest Ophthalmol Vis Sci 59(1):433–438. https://doi.org/10.1167/iovs.17-23202
Funding
This study was funded by a Foundation Fighting Blindness Career Development Award CD-RM-0918–0749-JHU (MSS), the Hartwell Foundation, the Shulsky Foundation, the Joseph Albert Hekimian Fund, Research to Prevent Blindness (unrestricted grant to the Wilmer Eye Institute), and the Wilmer Biostatistics Core Grant EY01765. The sponsors or funding organizations had no role in the design or conduct of this research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of Johns Hopkins University and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was waived given the retrospective nature of the study.
Conflict of interest
The authors declare no competing interests.
Disclaimer
Its contents are solely the responsibility of the authors and do not necessarily represent the official view of funders.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ong, S.S., Liu, T.Y.A., Li, X. et al. Choriocapillaris flow loss in center-involving retinitis pigmentosa: a quantitative optical coherence tomography angiography study using a novel classification system. Graefes Arch Clin Exp Ophthalmol 259, 3235–3242 (2021). https://doi.org/10.1007/s00417-021-05223-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-021-05223-y